COMMENT ON MITOXANTRONE

被引:14
作者
DUKART, G [1 ]
IATROPOULOS, MJ [1 ]
YACOBI, A [1 ]
机构
[1] AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,PEARL RIVER,NY 10965
来源
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1985年 / 19卷 / 03期
关键词
D O I
10.1177/106002808501900317
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:216 / 218
页数:3
相关论文
共 14 条
  • [1] ADAMSON RH, 1974, CANCER CHEMOTH REP 1, V58, P293
  • [2] SERIAL ASSESSMENT OF DOXORUBICIN CARDIOTOXICITY WITH QUANTITATIVE RADIONUCLIDE ANGIOCARDIOGRAPHY
    ALEXANDER, J
    DAINIAK, N
    BERGER, HJ
    GOLDMAN, L
    JOHNSTONE, D
    REDUTO, L
    DUFFY, T
    SCHWARTZ, P
    GOTTSCHALK, A
    ZARET, BL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) : 278 - 283
  • [3] BENJAMIN RS, 1984, MAY AM SOC CLIN ONC
  • [4] MITOXANTRONE - A REPLACEMENT FOR DOXORUBICIN
    CONNER, CS
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 479 - 480
  • [5] COMPARATIVE CARDIAC OXYGEN RADICAL METABOLISM BY ANTHRACYCLINE ANTIBIOTICS, MITOXANTRONE, BISANTRENE, 4'-(9-ACRIDINYLAMINO)-METHANESULFON-META-ANISIDIDE, AND NEOCARZINOSTATIN
    DOROSHOW, JH
    DAVIES, KJA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1983, 32 (19) : 2935 - 2939
  • [6] DOROSHOW JH, 1983, CANCER RES, V43, P4543
  • [7] DUKART G, 1984, PHARMANUAL COMPREHEN
  • [8] FENOGLIO JJ, 1983, CARDIOVASC PATHOL, V2, P1085
  • [9] HENDERSON IC, 1984, MAY AM SOC CLIN ONC
  • [10] IATROPOULOS MJ, 1984, CANCER TREAT S, V3, P380